Vinod Balachandran, Founding Director, The Olayan Center for Cancer Vaccines at Memorial Sloan Kettering Cancer Center, shared a post by Jonathan Reiner, director of the cardiac catheterization laboratory at The George Washington University Hospital, adding:
“Excited to share these data at the Cancer Vaccine Session on Monday at AACR2026!”
Quoting Jonathan Reiner‘s post:
“Long term follow up of a phase 1 trial of an mRNA tumor vaccine shows that 7/8 patients with pancreatic cancer, who mounted an immune response to the vaccine, are still alive 6 years later. This is breathtaking data and shows the promise of mRNA vaccines.”
Other articles featuring Vinod Balachandran on OncoDaily.